Search
Mesothelioma Treatment Options Asbestos Exposure News Veterans And Mesothelioma About ELSS FREE Case Evaluation Top Mesothelioma Doctors

Larry Kaiser, M.D.
Dr. Larry Kaiser is President of The University of Texas Health Science Center at Houston. His past research interests include malignant mesothelioma treatment.

Claire Verschraegen, M.D.
Dr. Claire Verschraegen is a leading expert in malignant peritoneal mesothelioma and is the Director of the Translational Therapeutics and Phase I Program at the University of New Mexico Cancer Center in Albuquerque.

This website is certified by Health On the Net Foundation. Click to verify. We comply with the HONcode standard for trustworthy health information:
verify here.

Free Mesothelioma Information Packet

Enter your information to receive a comprehensive mesothelioma packet free of charge at your doorstep within 24 hours.

Yes   No

Laparoscopy and mesothelioma

malignant mesothelioma is a well-recognized long-term sequela of chronic asbestos exposure. Asbestos use in the United States began in the 1950s and was widespread until the mid-1970s. Although currently only 2.2 cases per million population per year are diagnosed, disease incidence is increasing because of the long latency of this neoplasm. A latency of 15-50 years means that a higher incidence of this neoplasm can be anticipated in the future. The authors report a patient with peritoneal mesothelioma and no known prior exposure to asbestos. The diagnosis was confirmed by exploratory laparoscopy, which entailed biopsies of the diaphragm and of the peritoneal and abdominal walls, and by cytologic evaluation of 700 ml ascitis fluid. At present, exploratory laparoscopy offers the quickest, safest, and least invasive way to confirm the clinical diagnosis of peritoneal malignant mesothelioma.

Source

PMID: 10522541

If you have any questions regarding treatment options or your legal rights, please contact us.